- Home
- GDTC vs EQ Comparison
GDTC vs EQ Comparison
Compare GDTC & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- EQ
- Stock Information
- Founded
- GDTC 2018
- EQ 2017
- Country
- GDTC Singapore
- EQ United States
- Employees
- GDTC N/A
- EQ N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- EQ Biotechnology: Pharmaceutical Preparations
- Sector
- GDTC Health Care
- EQ Health Care
- Exchange
- GDTC Nasdaq
- EQ Nasdaq
- Market Cap
- GDTC 28.0M
- EQ N/A
- IPO Year
- GDTC 2023
- EQ 2018
- Fundamental
- Price
- GDTC $2.30
- EQ $0.40
- Analyst Decision
- GDTC Buy
- EQ Buy
- Analyst Count
- GDTC 1
- EQ 3
- Target Price
- GDTC $5.00
- EQ $3.00
- AVG Volume (30 Days)
- GDTC 29.9K
- EQ 84.3K
- Earning Date
- GDTC 01-01-0001
- EQ 05-16-2025
- Dividend Yield
- GDTC N/A
- EQ N/A
- EPS Growth
- GDTC N/A
- EQ N/A
- EPS
- GDTC N/A
- EQ N/A
- Revenue
- GDTC $368,838.00
- EQ $41,095,000.00
- Revenue This Year
- GDTC N/A
- EQ N/A
- Revenue Next Year
- GDTC N/A
- EQ N/A
- P/E Ratio
- GDTC N/A
- EQ N/A
- Revenue Growth
- GDTC 264.63
- EQ 13.89
- 52 Week Low
- GDTC $1.20
- EQ $0.34
- 52 Week High
- GDTC $4.05
- EQ $1.89
- Technical
- Relative Strength Index (RSI)
- GDTC 46.24
- EQ 37.28
- Support Level
- GDTC $2.21
- EQ $0.34
- Resistance Level
- GDTC $2.56
- EQ $0.45
- Average True Range (ATR)
- GDTC 0.13
- EQ 0.04
- MACD
- GDTC -0.00
- EQ 0.00
- Stochastic Oscillator
- GDTC 31.58
- EQ 39.33
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.